Molecular Diagnostics

SAN FRANCISCO, Calif. – April 13, 2021 – Cofactor Genomics, the company bridging the precision medicine gap, today announced commencement of the first multicenter clinical trial of its [...]

Cofactor Genomics Cements Clinical Diagnostic Plans as Immunotherapy Prediction Data Builds Mar 16, 2021 | Molika Ashford NEW YORK – Cofactor Genomics has expanded the exploration of potential [...]

In cancer treatment, time is of critical importance. According to the American Cancer Society, an estimated 42% of all cancer cases in the U.S., as well as roughly 45% of cancer deaths, can be [...]

By Danielle M. Quintanilha, PhD Cancer is not only a deeply devastating disease for patients and their families, but is cited as the second leading cause of death (29%) in the country, second [...]

By Rachel Wellinghoff Disease is complex. This statement seems so evident, but behind it lies an entirely new way to approach oncology. Previous methods have targeted single analytes, prescribing [...]

Tumor-infiltrating lymphocytes (TILs) are lymphocytes that directly infiltrate the tumor microenvironment (TME) opposing or surrounding tumor cells and in some cases subsets of cancer-reactive [...]

By Zachary Bradley   Cell Surface Markers The human body is a complex environment made up of many different types of cells interacting with one another as well as their environment. In order [...]

By Kevin Flanagan, PhD Oncologists and cancer patients alike carefully track tumor status. The tumor is growing. The tumor is shrinking. The tumor has spread. The tumor is stable. There are new [...]

By Raymund Bueno, PhD Immunohistochemistry (IHC) is a method performed in the lab to identify specific antigens or analytes in a tissue sample using monoclonal or polyclonal antibodies¹ (see [...]

Cancer Molecular Subtypes Molecular subtyping refers to the use of -omics data to find clusters of tumors within a cancer type that have shared characteristics. Whereas earlier attempts to find [...]